425 related articles for article (PubMed ID: 26516853)
1. Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.
Lucena SR; Salazar N; Gracia-Cazaña T; Zamarrón A; González S; Juarranz Á; Gilaberte Y
Int J Mol Sci; 2015 Oct; 16(10):25912-33. PubMed ID: 26516853
[TBL] [Abstract][Full Text] [Related]
2. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
3. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Bahner JD; Bordeaux JS
Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
6. Surgery combined with photodynamic therapy versus surgery alone for the treatment of non-melanoma skin cancer and actinic keratosis: A retrospective cohort study.
Yang W; Liu L; Yang W; Wang D
Dermatol Ther; 2022 Aug; 35(8):e15652. PubMed ID: 35716107
[TBL] [Abstract][Full Text] [Related]
7. In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC.
Nicolás-Morala J; Portillo-Esnaola M; Terrén S; Gutiérrez-Pérez M; Gilaberte Y; González S; Juarranz Á
J Photochem Photobiol B; 2022 Aug; 233():112483. PubMed ID: 35679749
[TBL] [Abstract][Full Text] [Related]
8. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
Sidoroff A; Thaler P
Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
[TBL] [Abstract][Full Text] [Related]
9. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
10. Current treatments of actinic keratosis.
Gold MH; Nestor MS
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
[TBL] [Abstract][Full Text] [Related]
11. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part II: Photodynamic Therapy, Vismodegib, Cetuximab, Intralesional Methotrexate, and Radiotherapy.
Gracia-Cazaña T; Salazar N; Zamarrón A; Mascaraque M; Lucena SR; Juarranz Á
Actas Dermosifiliogr; 2016 Nov; 107(9):740-750. PubMed ID: 27436804
[TBL] [Abstract][Full Text] [Related]
12. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis.
Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T
Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912
[TBL] [Abstract][Full Text] [Related]
14. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for basal cell carcinoma.
Fargnoli MC; Peris K
Future Oncol; 2015 Nov; 11(22):2991-6. PubMed ID: 26550910
[TBL] [Abstract][Full Text] [Related]
16. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
17. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
18. Nonsurgical treatment of nonmelanoma skin cancer in the mature patient.
Čeović R; Petković M; Mokos ZB; Kostović K
Clin Dermatol; 2018; 36(2):177-187. PubMed ID: 29566922
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
Morton CA
J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
[TBL] [Abstract][Full Text] [Related]
20. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.
Lehmann P
Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]